Genentech, Inc.
South San Francisco, CA
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Metabolic & endocrine · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health
Genentech, Inc. is a clinical trial sponsor based in South San Francisco, CA. It has 43 active clinical trials with 8,455 planned participants, across 15 therapeutic areas. Since 2021 it has completed 80 trials and stopped 21 early. Its FDA record on file shows 2 inspections.
Trial track record · since 2021
FDA record
Recent FDA actions
Pipeline · 43 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
41 approved drug applications with a product on the market.
Questions about Genentech, Inc
No warning letter naming Genentech, Inc is on file. FDA has published 2 inspection classifications naming it.
FDA has posted 2 inspection classifications naming Genentech, Inc (2 NAI). The latest inspection ended on 2026-05-15 and was classified NAI (no action indicated). FDA posts a classification after its review, often months after the inspection ended.
Genentech, Inc is lead sponsor of 43 active clinical trials on ClinicalTrials.gov, with 8,455 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 80 trials and stopped 21 early.
Genentech, Inc is based in South San Francisco, CA. The address is the one on its FDA records or ClinicalTrials.gov registrations, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Genentech, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Genentech, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.